mouse anti nestin Search Results


94
Miltenyi Biotec nestin pe
Nestin Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nestin pe/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
nestin pe - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

93
R&D Systems nestin mouse
ARHGAP31 /CdGAP is associated with undifferentiated cells, and its downregulation provokes Cdc42 overexpression. A mRNA expression of ARHGAP31 in adrenergic tumors, mesenchymal tumors or neural crest tissues. Long rank test p value is shown, * = p < 0.05. Dataset: GSE908030. B mRNA expression of ARHGAP31 in SK-N-SH CD44hi-derived undifferentiated secondary tumorspheres (TS2) compared to the bulk cell line. * = p < 0.05, n = 4. C Immunofluorescence showing CdGAP expression in NB48T CD44hi-derived undifferentiated tumorspheres compared to CD44negative-derived ones. D Tumorsphere formation efficiency of SK-N-SH or NB48T PDX-derived cell lines after CdGAP knock down by siRNA or control. * = p < 0.05; *** = p < 0.005. E Expression of the undifferentiated marker <t>nestin</t> in SK-N-SH and NB48T PDX-derived tumorspheres after CdGAP knock down by siRNA or control. ** = p < 0.01; **** = p < 0.001. F Expression of Cdc42 in SK-N-SH and NB48T PDX-derived TS cells after CdGAP knock down by siRNA or control. Representative images from NB48T cells are shown. **** = p < 0.001. G Expression of Sox9 protein in cells from tumorspheres generated from NB48T or sorted CD44hi SK-N-SH and NB48T cells, after CdGAP knock down by siRNA or control. * = p < 0.05; **** = p < 0.001. H Cell viability in CHLA 20 cells, with or without downregulation of CdGAP, over 72 h (** = p < 0.01). I Quantification of <t>proliferating</t> <t>Ki67</t> expressing cells in NB48T cells with or without downregulation of CdGAP. Graph shows mean ± SEM. Scale bar = 20μm. (* = p < 0.05, n = 3). J Morphological characterization of CHLA 20 and NB48T cells with or without downregulation of CdGAP. Cell segmentation on the cell contour is shown in red. Scale bar = 20 μm. K Immunofluorescence for acetylated tubulin, and DAPI in CHLA 20 cells with or without downregulation of CdGAP. The presence of acetylated tubulin in cell extensions is indicated with red asterisks. Scale bar = 20 μm. L Quantification of the cells positive for acetylated tubulin staining in cellular protrusions after the indicated treatments in CHLA20 cells (mean ± SEM, * = p < 0.05; ** = p < 0.001, n = 3)
Nestin Mouse, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nestin mouse/product/R&D Systems
Average 93 stars, based on 1 article reviews
nestin mouse - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

99
R&D Systems mouse nestin antibody
Figure 2: Differentiation of <t>neural</t> <t>progenitor</t> cells from iPSCs. Producing neural progenitor cells from iPSCs were manufactured using the Neural Induction Medium during Days 20-35 (Figure 2a and 2b; 2a with <t>nestin</t> antibody staining), and there was no significant alteration in the morphology of the the parallel cultured control group (Figure 2c).
Mouse Nestin Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse nestin antibody/product/R&D Systems
Average 99 stars, based on 1 article reviews
mouse nestin antibody - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

92
Bio-Rad 10c2
Figure 2: Differentiation of <t>neural</t> <t>progenitor</t> cells from iPSCs. Producing neural progenitor cells from iPSCs were manufactured using the Neural Induction Medium during Days 20-35 (Figure 2a and 2b; 2a with <t>nestin</t> antibody staining), and there was no significant alteration in the morphology of the the parallel cultured control group (Figure 2c).
10c2, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/10c2/product/Bio-Rad
Average 92 stars, based on 1 article reviews
10c2 - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

92
R&D Systems mouse monoclonal anti nestin phycoerythrin
Figure 2: Differentiation of <t>neural</t> <t>progenitor</t> cells from iPSCs. Producing neural progenitor cells from iPSCs were manufactured using the Neural Induction Medium during Days 20-35 (Figure 2a and 2b; 2a with <t>nestin</t> antibody staining), and there was no significant alteration in the morphology of the the parallel cultured control group (Figure 2c).
Mouse Monoclonal Anti Nestin Phycoerythrin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal anti nestin phycoerythrin/product/R&D Systems
Average 92 stars, based on 1 article reviews
mouse monoclonal anti nestin phycoerythrin - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

rat  (Bio-Rad)
93
Bio-Rad rat
Figure 2: Differentiation of <t>neural</t> <t>progenitor</t> cells from iPSCs. Producing neural progenitor cells from iPSCs were manufactured using the Neural Induction Medium during Days 20-35 (Figure 2a and 2b; 2a with <t>nestin</t> antibody staining), and there was no significant alteration in the morphology of the the parallel cultured control group (Figure 2c).
Rat, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rat/product/Bio-Rad
Average 93 stars, based on 1 article reviews
rat - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
R&D Systems nestin pe conjugated antibody
Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) <t>nestin-</t> and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.
Nestin Pe Conjugated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nestin pe conjugated antibody/product/R&D Systems
Average 90 stars, based on 1 article reviews
nestin pe conjugated antibody - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Merck KGaA mouse anti-nestin mab 353
Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) <t>nestin-</t> and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.
Mouse Anti Nestin Mab 353, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-nestin mab 353/product/Merck KGaA
Average 90 stars, based on 1 article reviews
mouse anti-nestin mab 353 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Merck KGaA mouse anti-nestin
Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) <t>nestin-</t> and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.
Mouse Anti Nestin, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-nestin/product/Merck KGaA
Average 90 stars, based on 1 article reviews
mouse anti-nestin - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc mouse anti-nestin
Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) <t>nestin-</t> and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.
Mouse Anti Nestin, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-nestin/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
mouse anti-nestin - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Immunotec inc mouse anti-human nestin
Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) <t>nestin-</t> and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.
Mouse Anti Human Nestin, supplied by Immunotec inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human nestin/product/Immunotec inc
Average 90 stars, based on 1 article reviews
mouse anti-human nestin - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Becton Dickinson mouse anti-nestin 556309
Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) <t>nestin-</t> and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.
Mouse Anti Nestin 556309, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-nestin 556309/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
mouse anti-nestin 556309 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


ARHGAP31 /CdGAP is associated with undifferentiated cells, and its downregulation provokes Cdc42 overexpression. A mRNA expression of ARHGAP31 in adrenergic tumors, mesenchymal tumors or neural crest tissues. Long rank test p value is shown, * = p < 0.05. Dataset: GSE908030. B mRNA expression of ARHGAP31 in SK-N-SH CD44hi-derived undifferentiated secondary tumorspheres (TS2) compared to the bulk cell line. * = p < 0.05, n = 4. C Immunofluorescence showing CdGAP expression in NB48T CD44hi-derived undifferentiated tumorspheres compared to CD44negative-derived ones. D Tumorsphere formation efficiency of SK-N-SH or NB48T PDX-derived cell lines after CdGAP knock down by siRNA or control. * = p < 0.05; *** = p < 0.005. E Expression of the undifferentiated marker nestin in SK-N-SH and NB48T PDX-derived tumorspheres after CdGAP knock down by siRNA or control. ** = p < 0.01; **** = p < 0.001. F Expression of Cdc42 in SK-N-SH and NB48T PDX-derived TS cells after CdGAP knock down by siRNA or control. Representative images from NB48T cells are shown. **** = p < 0.001. G Expression of Sox9 protein in cells from tumorspheres generated from NB48T or sorted CD44hi SK-N-SH and NB48T cells, after CdGAP knock down by siRNA or control. * = p < 0.05; **** = p < 0.001. H Cell viability in CHLA 20 cells, with or without downregulation of CdGAP, over 72 h (** = p < 0.01). I Quantification of proliferating Ki67 expressing cells in NB48T cells with or without downregulation of CdGAP. Graph shows mean ± SEM. Scale bar = 20μm. (* = p < 0.05, n = 3). J Morphological characterization of CHLA 20 and NB48T cells with or without downregulation of CdGAP. Cell segmentation on the cell contour is shown in red. Scale bar = 20 μm. K Immunofluorescence for acetylated tubulin, and DAPI in CHLA 20 cells with or without downregulation of CdGAP. The presence of acetylated tubulin in cell extensions is indicated with red asterisks. Scale bar = 20 μm. L Quantification of the cells positive for acetylated tubulin staining in cellular protrusions after the indicated treatments in CHLA20 cells (mean ± SEM, * = p < 0.05; ** = p < 0.001, n = 3)

Journal: Cell Communication and Signaling : CCS

Article Title: Rho GTPases signaling mediates aggressiveness and differentiation in neuroblastoma tumors

doi: 10.1186/s12964-025-02649-3

Figure Lengend Snippet: ARHGAP31 /CdGAP is associated with undifferentiated cells, and its downregulation provokes Cdc42 overexpression. A mRNA expression of ARHGAP31 in adrenergic tumors, mesenchymal tumors or neural crest tissues. Long rank test p value is shown, * = p < 0.05. Dataset: GSE908030. B mRNA expression of ARHGAP31 in SK-N-SH CD44hi-derived undifferentiated secondary tumorspheres (TS2) compared to the bulk cell line. * = p < 0.05, n = 4. C Immunofluorescence showing CdGAP expression in NB48T CD44hi-derived undifferentiated tumorspheres compared to CD44negative-derived ones. D Tumorsphere formation efficiency of SK-N-SH or NB48T PDX-derived cell lines after CdGAP knock down by siRNA or control. * = p < 0.05; *** = p < 0.005. E Expression of the undifferentiated marker nestin in SK-N-SH and NB48T PDX-derived tumorspheres after CdGAP knock down by siRNA or control. ** = p < 0.01; **** = p < 0.001. F Expression of Cdc42 in SK-N-SH and NB48T PDX-derived TS cells after CdGAP knock down by siRNA or control. Representative images from NB48T cells are shown. **** = p < 0.001. G Expression of Sox9 protein in cells from tumorspheres generated from NB48T or sorted CD44hi SK-N-SH and NB48T cells, after CdGAP knock down by siRNA or control. * = p < 0.05; **** = p < 0.001. H Cell viability in CHLA 20 cells, with or without downregulation of CdGAP, over 72 h (** = p < 0.01). I Quantification of proliferating Ki67 expressing cells in NB48T cells with or without downregulation of CdGAP. Graph shows mean ± SEM. Scale bar = 20μm. (* = p < 0.05, n = 3). J Morphological characterization of CHLA 20 and NB48T cells with or without downregulation of CdGAP. Cell segmentation on the cell contour is shown in red. Scale bar = 20 μm. K Immunofluorescence for acetylated tubulin, and DAPI in CHLA 20 cells with or without downregulation of CdGAP. The presence of acetylated tubulin in cell extensions is indicated with red asterisks. Scale bar = 20 μm. L Quantification of the cells positive for acetylated tubulin staining in cellular protrusions after the indicated treatments in CHLA20 cells (mean ± SEM, * = p < 0.05; ** = p < 0.001, n = 3)

Article Snippet: For immunofluorescence, cells were fixed with 4% PFA in PBS for 15 min, permeabilized with 0.2% Triton X-100 in PBS for 10 min at 4 °C and blocked with PBS + 1% BSA for at least 1 h. Primary antibodies used were: CD44 mouse (1:200 BD Pharmingen), Cdc42 rabbit (1:1000 Cell Signaling), Ki67 rabbit (1:200 Thermo Scientific), Nestin rabbit (1:1000 Millipore), Nestin mouse (1:1000 R&D Systems), α-tubulin mouse (1:1000 Sigma), acetylated tubulin mouse (1:1000, Santa Cruz), Tuj1-βIII tubulin mouse (1:1000 abcam) and CdGAP (1:500, Santa Cruz).

Techniques: Over Expression, Expressing, Derivative Assay, Immunofluorescence, Knockdown, Control, Marker, Generated, Staining

Figure 2: Differentiation of neural progenitor cells from iPSCs. Producing neural progenitor cells from iPSCs were manufactured using the Neural Induction Medium during Days 20-35 (Figure 2a and 2b; 2a with nestin antibody staining), and there was no significant alteration in the morphology of the the parallel cultured control group (Figure 2c).

Journal: Journal of Stem Cell Research & Therapy

Article Title: No Detection of Potential Cancer Risk for Free-Viral Reprogrammed Stem Cell-Derived Dopaminergic Neurons from Adult Mice Fibroblasts

doi: 10.4172/2157-7633.1000286

Figure Lengend Snippet: Figure 2: Differentiation of neural progenitor cells from iPSCs. Producing neural progenitor cells from iPSCs were manufactured using the Neural Induction Medium during Days 20-35 (Figure 2a and 2b; 2a with nestin antibody staining), and there was no significant alteration in the morphology of the the parallel cultured control group (Figure 2c).

Article Snippet: Mouse Nestin Antibody (R & D system, MAB2736) was applied as a neural progenitor mark for the verification of neuronal progenitor cells.

Techniques: Staining, Cell Culture, Control

Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) nestin- and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.

Journal: iScience

Article Title: Enhanced differentiation of neural progenitor cells in Alzheimer’s disease into vulnerable immature neurons

doi: 10.1016/j.isci.2025.112446

Figure Lengend Snippet: Enhanced neuronal activity and early differentiation in APPswe cerebral organoids (A–C) Quantification of the perimeter (B) and area (C) of control and APPswe cerebral organoids cultured for one month. n = 80–104, from 3 independent differentiations. Scale bar, 500 μm. (D–F) Neuronal activity was measured by a multi-electrode array in control and APPswe cerebral organoids cultured for one month. n = 11–12, from 3 independent differentiations. (G–I) Immunohistochemistry was performed to analyze the distribution of (H) nesitn- and (I) DCX-positive cells in control and APPswe cerebral organoids cultured for one month. n = 9, from 3 independent differentiations. Scale bar, 20 μm. (J–M) Immunoblotting to determine expression levels of SOX2 (K), DCX (L), and TUJ1 (M) in control and APPswe cerebral organoids cultured for one month. n = 10–14, from 3 independent differentiations. (N–P) Flow cytometry analysis was performed on control and APPswe cerebral organoids cultured for one month to assess the expression levels of (O) nestin- and (P) DCX-positive populations. n = 3 from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 (Student’s t test). Error bar ± SEM.

Article Snippet: After blocking, the cells were incubated for 2 hours at 4°C with primary antibodies: a nestin PE-conjugated antibody (R&D Systems) and an antibody against DCX.

Techniques: Activity Assay, Control, Cell Culture, Immunohistochemistry, Western Blot, Expressing, Flow Cytometry

Increased mitochondrial ROS and its impact on early differentiation in APPswe NPCs (A–C) Immunocytochemistry analysis of nestin (B) and DCX (C) in control and APPswe NPCs and neurons, differentiated for one week. Scale bar, 40 μm. NPCs, n = 30, from 3 independent differentiations; neuron, n = 75, from 6 independent differentiations. (D) Increased MitoSOX signal in APPswe NPCs. n = 3, from 3 independent differentiations. (E) Reduced utilization of OXPHOS in glucose metabolism in APPswe NPCs. n = 5, from 3 independent differentiations. (F–H) Normalization of increased nestin (G) and decreased DCX (H) expression in APPswe NPCs with EUK8 treatment. Scale bar, 40 μm. n = 75, from 5 independent differentiations. (I) Schematic of the experiment categorizing control NPCs into high-ROS and low-ROS groups based on MitoSOX signal intensity. (J–L) No significant differences in nestin and DCX expression between high-ROS and low-ROS NPC groups. Scale bar, 20 μm. n = 40, from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (ANOVA test followed by Dunnett’s post hoc analysis or Student’s t test). Error bar ± SEM.

Journal: iScience

Article Title: Enhanced differentiation of neural progenitor cells in Alzheimer’s disease into vulnerable immature neurons

doi: 10.1016/j.isci.2025.112446

Figure Lengend Snippet: Increased mitochondrial ROS and its impact on early differentiation in APPswe NPCs (A–C) Immunocytochemistry analysis of nestin (B) and DCX (C) in control and APPswe NPCs and neurons, differentiated for one week. Scale bar, 40 μm. NPCs, n = 30, from 3 independent differentiations; neuron, n = 75, from 6 independent differentiations. (D) Increased MitoSOX signal in APPswe NPCs. n = 3, from 3 independent differentiations. (E) Reduced utilization of OXPHOS in glucose metabolism in APPswe NPCs. n = 5, from 3 independent differentiations. (F–H) Normalization of increased nestin (G) and decreased DCX (H) expression in APPswe NPCs with EUK8 treatment. Scale bar, 40 μm. n = 75, from 5 independent differentiations. (I) Schematic of the experiment categorizing control NPCs into high-ROS and low-ROS groups based on MitoSOX signal intensity. (J–L) No significant differences in nestin and DCX expression between high-ROS and low-ROS NPC groups. Scale bar, 20 μm. n = 40, from 3 independent differentiations. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 (ANOVA test followed by Dunnett’s post hoc analysis or Student’s t test). Error bar ± SEM.

Article Snippet: After blocking, the cells were incubated for 2 hours at 4°C with primary antibodies: a nestin PE-conjugated antibody (R&D Systems) and an antibody against DCX.

Techniques: Immunocytochemistry, Control, Expressing